Sriam Labs Private Limited - pharma in Yadadri Bhuvanagiri, Telangana, India. FY 2026 financials & compliance.
CIN U24239AP2002PTC121365 Incorporated 12 February 2002 ROC Hyderabad HQ Yadadri Bhuvanagiri, Telangana, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2026
₹77.88 Cr
▲ 24% YoY
Net profit · FY 2026
₹5.16 Cr
Net margin 6.6%
EBITDA · FY 2026
₹6.4 Cr
EBITDA margin 8.2%
Authorised capital
₹14.5 Cr
Registered with MCA
Paid-up capital
₹14.2 Cr
Issued & subscribed
Satisfied charges
₹84.73 Cr
No open charges
Company age
24 yrs
Est. 2002
Employees · EPFO
97
Provident fund records

About Sriam Labs Private Limited

Data last updated:

Sriam Labs Private Limited is a private limited company based in Yadadri Bhuvanagiri, Telangana, India, a subsidiary of Laurus Labs Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 12 February 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239AP2002PTC121365. Its GSTIN is 36AADCP0811A1Z6 (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹14.5 Cr and a paid-up capital of ₹14.2 Cr. It was formerly known as Sai Ram Organics Private Limited. It is led by directors including Uma Maheswar Rao Vasireddi and Venkata Lakshmana Rao Chunduru.

Its last annual general meeting (AGM) was held on 12 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sy. No. 505 Padamati Somaram Road Bibinagar (Village & Mandal), Yadadri Bhuvanagiri, Telangana, India – 508126.

As per the financials filed for FY 2026, the company reported a revenue of ₹77.88 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹5.16 Cr (net margin 6.6%) and EBITDA of ₹6.4 Cr (EBITDA margin 8.2%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.

The company has about 97 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Laurus Labs. As per MCA filings, the company has satisfied charges of ₹84.73 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.32 Cr; the latest was in November 2016. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Kshatriya Laboratories Private Limited with revenue of ₹65.76 Cr.

Sriam Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-30-0000108). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sriam-labs.lookchem.com.

Company details

CIN U24239AP2002PTC121365
Registration Number 038490
Incorporation Date 12 February 2002
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 12 June 2025
Date of Balance Sheet 31 March 2025
Parent Company Laurus Labs Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-30-0000108

CIN history

Sriam Labs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239AP2002PTC121365, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239AP2002PTC121365Current
U24239TG2002PTC038490Previous
U24239AP2002PTC038490Previous

Recognitions & Rankings of Sriam Labs

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-30-0000108

Contact details

Sriam Labs Private Limited's registered office is in Yadadri Bhuvanagiri, Telangana.

  • Social Media
  • Registered Address
    Sy. No. 505 Padamati Somaram Road Bibinagar (Village & Mandal), Yadadri Bhuvanagiri, Telangana, India – 508126
  • Industry
    Pharma, API Manufacturers
Comprehensive company report
Sriam Labs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sriam Labs operates one associated brand: Laurus Labs. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical and biotechnology companylauruslabs.com

Business activity

The main business activity of Sriam Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sriam Labs Private Limited, buy the company report.

Financials of Sriam Labs Private Limited

FY 2025 filings available

Sriam Labs Private Limited reported revenue of ₹77.88 Cr (up 24% YoY) for FY 2026.

Revenue · FY 2026
₹77.88 Cr ▲ 24%
Net profit · FY 2026
₹5.16 Cr margin 6.6%
EBITDA · FY 2026
₹6.4 Cr margin 8.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▼ 1%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▼ 20%
5 years · compounded
▼ 19%

Revenue rose 24% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.4 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.16 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin8.2%
Net Profit Margin6.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sriam Labs Private Limited, buy the company report.

Board of directors and KMP of Sriam Labs Private Limited

Sriam Labs Private Limited currently reports 4 directors and 1 key managerial person. 9 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Venkateswar Reddy GogireddyCompany Secretary01 Apr 20206 Years 6 MonthsCurrent
Uma Maheswar Rao VasireddiDirector23 Jul 20206 Years 3 MonthsCurrent
Venkata Lakshmana Rao ChunduruDirector25 Jul 201412 Years 3 MonthsCurrent
Krishna Chaitanya ChavaDirector25 Jul 20197 Years 3 MonthsCurrent
Srinivasa Rao SuryadevaraDirector25 Jul 201412 Years 3 MonthsCurrent

Peer comparison

Sriam Labs Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sriam Labs Private Limitedthis company₹77.88 Cr (FY 2026)₹5.16 Cr6.6%24.0%Yadadri Bhuvanagiri, Telangana, India
Kshatriya Laboratories Private Limited₹65.76 Cr (FY 2022)-10.0%Hyderabad, Telangana, India
Arihantanam Lifecare Private Limited₹65.35 Cr (FY 2025)4.0%Sarigam, Gujarat, India
Regal Remedies Limited₹65.15 Cr (FY 2024)32.0%Mumbai, Maharashtra, India
Srikem Laboratories Private Limited₹64.78 Cr (FY 2024)20.0%Mumbai, Maharashtra, India
Chandra Life Sciences Private Limited₹63.01 Cr (FY 2024)4.0%Hyderabad, Telangana, India
Androst Biotech India Private Limited₹61.85 Cr (FY 2025)-12.0%Anand, Gujarat, India
Saptagir Laboratories Private Limited₹60.25 Cr (FY 2025)8.0%Hyderabad, Telangana, India
Cadchem Laboratories Limited₹59.73 Cr (FY 2024)-13.0%Chandigarh, India
Macsen Labs Limited₹59.7 Cr (FY 2025)-9.0%Udaipur, Rajasthan, India

To see the full peer comparison of Sriam Labs Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹84.73 Cr
Breakdown by lending institutions
Others₹29.60 Cr
Andhra Bank₹27.36 Cr
Axis Bank Limited₹10.00 Cr
Syndicate Bank₹9.65 Cr
State Bank of India₹7.65 Cr
Others₹0.47 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Dec 2020100406914Axis Bank Limited₹10 CrSatisfied
30 Apr 201510570646Andhra Bank₹6 CrSatisfied
21 Jan 201510548656Andhra Bank₹6.7 LakhSatisfied
18 Jun 201410510075Andhra Bank₹6 CrSatisfied
28 Jan 201310402446Andhra Bank₹5.6 CrSatisfied

To see the full charge records of Sriam Labs Private Limited, buy the company report.

Total charge records: 12 View all charges

Deals & funding

Sriam Labs Private Limited has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.32 Cr; the latest was in November 2016.

Total deals
6
Funding rounds
3
Secondary share transfers
3
Disclosed funding
₹14.32 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Nov 2016Secondary share transferUndisclosedBuyer: Laurus Labs Limited & Satyanarayana Chava, Laurus Labs Limited
Seller: 4 individuals
Apr 2014Funding round₹7.2 CrInvestors: Laurus Labs Limited
Mar 2012Funding round₹5.1 CrInvestors: 4 individuals
Feb 2011Secondary share transferUndisclosedBuyer: C R Eco Ventures Private Limited , 3 individuals
Seller: Lifecare Laboratories Private Limited , 3 individuals
Sep 2010Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 4 individuals

To see the full deal history of Sriam Labs Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Sriam Labs Private Limited was last rated by Care on 28 Jun 2021.

Rating agencyRated onRating
Care28 Jun 2021

To see the full credit ratings and regulatory alerts of Sriam Labs Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sriam Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sriam Labs has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AADCP0811A1Z6TelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Sriam Labs Private Limited, buy the company report.

Recent activity

Sriam Labs Private Limited has 13 board changes on record since 2011: 5 appointments and 8 cessations. The latest: Uma Maheswar Rao Vasireddi ceased to be Additional Director on 24 Jun 2021.

AGM
Sriam Labs Private Limited last Annual general meeting of members was held on 12 Jun 2025 as per latest MCA records.
Filing
Sriam Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 29 Dec 2020 via Charge ID 100406914 with Axis Bank Limited was fully satisfied on 02 Jul 2022.
Ceased
Uma Maheswar Rao Vasireddi ceased to be Additional Director.
Charges
A charge with Axis Bank Limited of Rs. 10.00 Cr registered on 29 Dec 2020 with Charge ID 100406914 was modified on 09 Mar 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100406914 was registered on 29 Dec 2020.
Appointed
Uma Maheswar Rao Vasireddi was appointed as Director.
Appointed
Venkateswar Reddy Gogireddy was appointed as Company Secretary.
Charges
A charge registered on 05 Sep 2011 via Charge ID 10308211 with Others was fully satisfied on 18 Mar 2020.
Ceased
Krishna Chaitanya Chava ceased to be Additional Director.
Appointed
Krishna Chaitanya Chava was appointed as Director.
Ceased
Seeta Ram Anjaneyulu Gorantla ceased to be Director.

32 earlier events are in the company report.

Frequently asked questions

Sriam Labs is an active private limited company based in Yadadri Bhuvanagiri, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 12 February 2002 (24+ years old) and is registered under CIN U24239AP2002PTC121365.

Sriam Labs has 5 current directors and KMP:

The latest financial statements of Sriam Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 12 June 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Sriam Labs is 36AADCP0811A1Z6, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Sriam Labs is U24239AP2002PTC121365. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sriam Labs has 1 court case on record: 1 filed by the company.

Sriam Labs was incorporated on 12 February 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.

Sriam Labs has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.32 Cr; the latest was in November 2016.

The peers of Sriam Labs by revenue are Kshatriya Laboratories Private Limited, Arihantanam Lifecare Private Limited, Regal Remedies Limited, Srikem Laboratories Private Limited, Chandra Life Sciences Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Uma Maheswar Rao Vasireddi ceased to be Additional Director on 24 Jun 2021. Uma Maheswar Rao Vasireddi was appointed as Director on 23 Jul 2020. Venkateswar Reddy Gogireddy was appointed as Company Secretary on 01 Apr 2020. Sriam Labs has 13 board changes on record in total.

Yes, Sriam Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-30-0000108).